IGA NEPHROPATHY
Clinical trials for IGA NEPHROPATHY explained in plain language.
Never miss a new study
Get alerted when new IGA NEPHROPATHY trials appear
Sign up with your email to follow new studies for IGA NEPHROPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug trial aims to protect kidneys from silent disease
Disease control OngoingThis study is testing whether a drug called atacicept can help control IgA nephropathy, a kidney disease. It will see if the drug safely reduces protein in the urine and slows the decline of kidney function in adults who are already on standard medication. The trial involves a tw…
Matched conditions: IGA NEPHROPATHY
Phase: PHASE3 • Sponsor: Vera Therapeutics, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
First human tests begin for new kidney disease drug
Disease control OngoingThis is an early-stage study to test the safety and effects of a new drug called ARO-CFB. It involves healthy volunteers and patients with kidney diseases caused by an overactive part of the immune system, like IgA Nephropathy. The main goal is to see how the body handles the dru…
Matched conditions: IGA NEPHROPATHY
Phase: PHASE1 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New drug trial aims to slow kidney damage in IgA nephropathy patients
Disease control OngoingThis study is testing whether the drug BION-1301 can help adults with IgA nephropathy, a kidney disease that can lead to kidney failure. About 383 participants will receive either the drug or a placebo injection every two weeks for two years. The main goal is to see if the drug r…
Matched conditions: IGA NEPHROPATHY
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Mar 24, 2026 12:03 UTC